Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting report.

Gsell, Pierre-Stéphane; Giersing, Birgitte; Gottlieb, Sami; Wilder-Smith, Annelies; Wu, Lindsey; Friede, Martin

Gsell, Pierre-Stéphane; Giersing, Birgitte; Gottlieb, Sami; Wilder-Smith, Annelies; Wu, Lindsey; Friede, Martin.

Afiliación

Gsell PS; World Health Organization, Geneva, Switzerland. Electronic address: gsellp@who.int.
Giersing B; World Health Organization, Geneva, Switzerland.
Gottlieb S; World Health Organization, Geneva, Switzerland.
Wilder-Smith A; World Health Organization, Geneva, Switzerland.
Wu L; World Health Organization, Geneva, Switzerland.
Friede M; World Health Organization, Geneva, Switzerland.

Vaccine ; 41(49): 7307-7312, 2023 Nov 30.

Article en En | MEDLINE | ID: mdl-37949751

Asunto(s)

Países en Desarrollo; Vacunas; Transferencia de Tecnología; Comercio; Organización Mundial de la Salud

Palabras clave

Local production; Technology transfer; mRNA vaccine R&D

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / Países en Desarrollo Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google